A framework for translating tauopathy therapeutics: Drug discovery to clinical trials.
- DOI
- 10.1002/alz.14250
- Published
- 2024-09-24
- Container
- Alzheimers Dement
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/alz.14250,
title = {A framework for translating tauopathy therapeutics: Drug discovery to clinical trials.},
author = {Feldman HH and Cummings JL and Boxer AL and Staffaroni AM and Knopman DS and Sukoff Rizzo SJ and Territo PR and Arnold SE and Ballard C and Beher D and Boeve BF and Dacks PA and Diaz K and Ewen C and Fiske B and Gonzalez MI and Harris GA and Hoffman BJ and Martinez TN and McDade E and Nisenbaum LK and Palma JA and Quintana M and Rabinovici GD and Rohrer JD and Rosen HJ and Troyer MD and Kim DY and Tanzi RE and Zetterberg H and Ziogas NK and May PC and Rommel A.},
year = {2024},
journal = {Alzheimers Dement},
doi = {10.1002/alz.14250},
url = {https://doi.org/10.1002/alz.14250}
}RIS
TY - JOUR TI - A framework for translating tauopathy therapeutics: Drug discovery to clinical trials. AU - Feldman HH AU - Cummings JL AU - Boxer AL AU - Staffaroni AM AU - Knopman DS AU - Sukoff Rizzo SJ AU - Territo PR AU - Arnold SE AU - Ballard C AU - Beher D AU - Boeve BF AU - Dacks PA AU - Diaz K AU - Ewen C AU - Fiske B AU - Gonzalez MI AU - Harris GA AU - Hoffman BJ AU - Martinez TN AU - McDade E AU - Nisenbaum LK AU - Palma JA AU - Quintana M AU - Rabinovici GD AU - Rohrer JD AU - Rosen HJ AU - Troyer MD AU - Kim DY AU - Tanzi RE AU - Zetterberg H AU - Ziogas NK AU - May PC AU - Rommel A. PY - 2024 JO - Alzheimers Dement DO - 10.1002/alz.14250 UR - https://doi.org/10.1002/alz.14250 ER -
APA
HH, F., JL, C., AL, B., AM, S., DS, K., SJ, S. R., PR, T., SE, A., C, B., D, B., BF, B., PA, D., K, D., C, E., B, F., MI, G., GA, H., BJ, H., TN, M., E, M., LK, N., JA, P., M, Q., GD, R., JD, R., HJ, R., MD, T., DY, K., RE, T., H, Z., NK, Z., PC, M., & A., R. (2024). A framework for translating tauopathy therapeutics: Drug discovery to clinical trials.. Alzheimers Dement. https://doi.org/10.1002/alz.14250
Source records
- europe-pmc · retrieved 2026-09-26T05:37:35.519Z